LYEL – lyell immunopharma, inc. (US:NASDAQ)
Stock Stats
News
Lyell Immunopharma, Inc. (NASDAQ: LYEL) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $1.00 price target on the stock.
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2024 [Yahoo! Finance]
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2024
Lyell Immunopharma Announces Participation in Upcoming Investor Conferences
Lyell Immunopharma, Inc. (NASDAQ:LYEL) has caught the attention of institutional investors who hold a sizeable 46% stake [Yahoo! Finance]
Form 4 Lyell Immunopharma, Inc. For: Mar 14 Filed by: Klausner Richard
Form 4 Lyell Immunopharma, Inc. For: Mar 17 Filed by: Newton Charles W.
Form 4 Lyell Immunopharma, Inc. For: Mar 14 Filed by: Seely Lynn
Form S-8 Lyell Immunopharma, Inc.
Form 10-K Lyell Immunopharma, Inc. For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.